These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21842599)

  • 1. [Pathogenic mechanism of membranous glomerulonephritis obtained from Heymann nephritis and human membranous glomerulonephritis].
    Kamata K
    Nihon Jinzo Gakkai Shi; 2011; 53(5):672-6. PubMed ID: 21842599
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary membranous nephropathy].
    Kimura Y; Imai H
    Nihon Jinzo Gakkai Shi; 2011; 53(5):697-702. PubMed ID: 21842603
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy.
    Ronco P; Debiec H
    J Am Soc Nephrol; 2010 Apr; 21(4):564-9. PubMed ID: 20185638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Membranous nephropathy: up to date].
    Imai E
    Nihon Jinzo Gakkai Shi; 2011; 53(5):692-6. PubMed ID: 21842602
    [No Abstract]   [Full Text] [Related]  

  • 6. Human idiopathic membranous nephropathy--a mystery solved?
    Glassock RJ
    N Engl J Med; 2009 Jul; 361(1):81-3. PubMed ID: 19571287
    [No Abstract]   [Full Text] [Related]  

  • 7. Heymann nephritis revisited--new insights into the pathogenesis of experimental membranous glomerulonephritis.
    De Heer E; Bruijn JA; Hoedemaeker PJ
    Clin Exp Immunol; 1993 Dec; 94(3):393-4. PubMed ID: 8252799
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular dissection of target antigens and nephritogenic antibodies in membranous nephropathy: towards epitope-driven therapies.
    Ronco P; Debiec H
    J Am Soc Nephrol; 2006 Jul; 17(7):1772-4. PubMed ID: 16775025
    [No Abstract]   [Full Text] [Related]  

  • 9. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.
    Debiec H; Ronco P
    N Engl J Med; 2011 Feb; 364(7):689-90. PubMed ID: 21323563
    [No Abstract]   [Full Text] [Related]  

  • 10. [Membranous glomerulonephritis (membranous nephropathy): Pathogenesis, pathophysiology, and therapy].
    Ohashi T; Uchida K; Yumura W
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():417-21. PubMed ID: 16523925
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molecular analysis of experimental membranous glomerulonephritis (Heymann nephritis)].
    Kerjaschki D
    Verh Dtsch Ges Pathol; 1996; 80():139-47. PubMed ID: 9064996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-phospholipase A2 receptor antibodies and the pathogenesis of membranous nephropathy.
    Ronco P; Debiec H
    Nephron Clin Pract; 2014; 128(3-4):232-7. PubMed ID: 25401774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Membranous glomerulonephritis: better therapy with autoantibody monitoring?].
    Stahl RA; Hoxha E; Helmchen U
    Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1733-7. PubMed ID: 21877306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranous nephropathy. Insights from Heymann nephritis.
    Cavallo T
    Am J Pathol; 1994 Apr; 144(4):651-8. PubMed ID: 8160766
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
    Ronco P; Allegri L; Brianti E; Chatelet F; Van Leer EH; Verroust P
    Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to glomerular antigens.
    Ronco P; Sahali D; Cittanova ML; van Leer EH; Chatelet F; Verroust P
    Nephrol Dial Transplant; 1992; 7 Suppl 1():9-15. PubMed ID: 1362802
    [No Abstract]   [Full Text] [Related]  

  • 17. Isologous monoclonal antibodies can induce anti-GBM glomerulonephritis in rats.
    Sado Y; Kagawa M; Rauf S; Naito I; Moritoh C; Okigaki T
    J Pathol; 1992 Oct; 168(2):221-7. PubMed ID: 1460540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression.
    Huang CC; Lehman A; Albawardi A; Satoskar A; Brodsky S; Nadasdy G; Hebert L; Rovin B; Nadasdy T
    Mod Pathol; 2013 Jun; 26(6):799-805. PubMed ID: 23328976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Membranous nephropathy].
    Yuzawa Y; Hasegawa M; Nabeshima K
    Nihon Jinzo Gakkai Shi; 2010; 52(7):894-8. PubMed ID: 21077337
    [No Abstract]   [Full Text] [Related]  

  • 20. Intramolecular epitope spreading in Heymann nephritis.
    Shah P; Tramontano A; Makker SP
    J Am Soc Nephrol; 2007 Dec; 18(12):3060-6. PubMed ID: 18003776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.